Greiner bio-one looks back on a very successful financial year 2020
Last edited: | Company - Back to overview
The COVID-19 pandemic dominated 2020, and Greiner Bio-One products played an important role.
Kremsmünster, May 2021 – With the rapid development of the VACUETTE® virus stabilization tube and an intense focus upon research and laboratory products of relevance to COVID-19, Greiner Bio-One is making a key contribution to the conquest of the pandemic. The careful management of production capacity and close cooperation with our customers constitute the basis for an extremely successful business picture.
